Impaired calcium calmodulin kinase signaling and muscle adaptation response in the absence of calpain 3

Human Molecular Genetics

Volumn 21, Issue 14, 2012, Pages 3193-3204

  Kramerova, I ^a   Kudryashova, E ^a   Ermolova, N ^a   Saenz, A ^b,d   Jaka, O ^b,d   Lopez de munain A ^b,c,d   Spencer, M J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALPAIN 3; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2A; MUSCLE PROTEIN; MYOSIN; UNCLASSIFIED DRUG;

ADAPTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOPSY TECHNIQUE; CALCIUM TRANSPORT; CONTROLLED STUDY; EXERCISE; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ADULT; ANIMALS; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALPAIN; DOWN-REGULATION; FEMALE; HUMANS; MALE; MICE; MICE, KNOCKOUT; MIDDLE AGED; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; SIGNAL TRANSDUCTION; YOUNG ADULT;

MUS;

EID: 84863992929     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds144     Document Type: Article

References (42)

1. Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C. et al. (1995) Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell, 81, 27-40.
2. Sorimachi, H., Hata, S. and Ono, Y. (2010) Expanding members and roles of the calpain superfamily and their genetically modified animals. Exp. Anim., 59, 549-566.
3. Kramerova, I., Beckmann, J.S. and Spencer, M.J. (2007) Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim. Biophys. Acta, 1772, 128-144.
4. Milic, A., Daniele, N., Lochmuller, H., Mora, M., Comi, G.P., Moggio, M., Noulet, F., Walter, M.C., Morandi, L., Poupiot, J. et al. (2007) A third of LGMD2A biopsies have normal calpain 3 proteolytic activity as determined by an in vitro assay. Neuromuscul. Disord., 17, 148-156.
5. Goll, D.E., Thompson, V.F., Li, H., Wei, W. and Cong, J. (2003) The calpain system. Physiol. Rev., 83, 731-801.
6. Diaz, B.G., Moldoveanu, T., Kuiper, M.J., Campbell, R.L. and Davies, P.L. (2004) Insertion sequence 1 of muscle-specific calpain, p94, acts as an internal propeptide. J. Biol. Chem., 279, 27656-27666.
7. Taveau, M., Bourg, N., Sillon, G., Roudaut, C., Bartoli, M. and Richard, I. (2003) Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol. Cell Biol., 23, 9127-9135.
8. Kramerova, I., Kudryashova, E., Wu, B., Ottenheijm, C., Granzier, H. and Spencer, M.J. (2008) Novel role of calpain-3 in the triad-associated protein complex regulating calcium release in skeletal muscle. Hum. Mol. Genet., 17, 3271-3280.
9. Franzini-Armstrong, C. (1994) The sarcoplasmic reticulum and the transverse tubules. In Engel, A.G. and Franzini-Armstrong, C. (eds), Myology. McGraw-Hill, Inc., New York, Vol. 1, pp. 176-199.
10. Dayanithi, G., Richard, I., Viero, C., Mazuc, E., Mallie, S., Valmier, J., Bourg, N., Herasse, M., Marty, I., Lefranc, G. et al. (2009) Alteration of sarcoplasmic reticulum Ca release in skeletal muscle from calpain 3-deficient mice. Int. J. Cell Biol., 2009, 340346.
11. Ojima, K., Ono, Y., Ottenheijm, C., Hata, S., Suzuki, H., Granzier, H. and Sorimachi, H. (2011) Non-proteolytic functions of calpain-3 in sarcoplasmic reticulum in skeletal muscles. J. Mol. Biol., 407, 439-449.
12. Chin, E.R. (2004) The role of calcium and calcium/calmodulin-dependent kinases in skeletal muscle plasticity and mitochondrial biogenesis. Proc. Nutr. Soc., 63, 279-286.
13. Bassel-Duby, R. and Olson, E.N. (2006) Signaling pathways in skeletal muscle remodeling. Ann. Rev. Biochem., 75, 19-37.
14. Fong, Y.L., Taylor, W.L., Means, A.R. and Soderling, T.R. (1989) Studies of the regulatory mechanism of Ca2+/calmodulin-dependent protein kinase II. Mutation of threonine 286 to alanine and aspartate. J. Biol. Chem., 264, 16759-16763.
15. Chin, E.R. (2005) Role of Ca2+/calmodulin-dependent kinases in skeletal muscle plasticity. J. Appl. Physiol., 99, 414-423.
16. Potthoff, M.J., Wu, H., Arnold, M.A., Shelton, J.M., Backs, J., McAnally, J., Richardson, J.A., Bassel-Duby, R. and Olson, E.N. (2007) Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest., 117, 2459-2467.
17. Ermolova, N., Kudryashova, E., DiFranco, M., Vergara, J., Kramerova, I. and Spencer, M.J. (2011) Pathogenity of some limb girdle muscular dystrophy mutations can result from reduced anchorage to myofibrils and altered stability of calpain 3. Hum. Mol. Genet., 20, 3331-3345.
18. Zorzato, F., Jungbluth, H., Zhou, H., Muntoni, F. and Treves, S. (2007) Functional effects of mutations identified in patients with multiminicore disease. IUBMB Life, 59, 14-20.
19. Zhou, H., Jungbluth, H., Sewry, C.A., Feng, L., Bertini, E., Bushby, K., Straub, V., Roper, H., Rose, M.R., Brockington, M. et al. (2007) Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain, 130, 2024-2036.
20. Dubowitz, V. and Sewry, C.A. (2007) Muscle Biopsy: A Practical Approach. Sanders/Elsevier, Edinburgh.
21. Sugiura, T., Miyata, H., Kawai, Y., Matoba, H. and Murakami, N. (1993) Changes in myosin heavy chain isoform expression of overloaded rat skeletal muscles. Int. J. Biochem., 25, 1609-1613.
22. Kramerova, I., Kudryashova, E., Wu, B., Germain, S., Vandenborne, K., Romain, N., Haller, R., Verity, M.A. and Spencer, M.J. (2009) Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. Hum. Mol. Genet., 18, 3194-3205.
23. Kho, A.T., Kang, P.B., Kohane, I.S. and Kunkel, L.M. (2006) Transcriptome-scale similarities between mouse and human skeletal muscles with normal and myopathic phenotypes. BMC Musculoskelet. Disord., 7, 23-31.
24. Talmadge, R.J. (2000) Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve, 23, 661-679.
25. Fluck, M., Waxham, M.N., Hamilton, M.T. and Booth, F.W. (2000) Skeletal muscle Ca(2+)-independent kinase activity increases during either hypertrophy or running. J. Appl. Physiol., 88, 352-358.
26. Kolodziej, S.J., Hudmon, A., Waxham, M.N. and Stoops, J.K. (2000) Three-dimensional reconstructions of calcium/calmodulin-dependent (CaM) kinase IIalpha and truncated CaM kinase IIalpha reveal a unique organization for its structural core and functional domains. J. Biol. Chem., 275, 14354-14359.
27. Soderling, T.R., Chang, B. and Brickey, D. (2001) Cellular signaling through multifunctional Ca2+/calmodulin-dependent protein kinase II. J. Biol. Chem., 276, 3719-3722.
28. Kramerova, I., Kudryashova, E., Venkatraman, G. and Spencer, M.J. (2005) Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. Hum. Mol. Genet., 14, 2125-2134.
29. Witczak, C.A., Jessen, N., Warro, D.M., Toyoda, T., Fujii, N., Anderson, M.E., Hirshman, M.F. and Goodyear, L.J. (2010) CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 298, E1150-E1160.
30. Chae, J., Minami, N., Jin, Y., Nakagawa, M., Murayama, K., Igarashi, F. and Nonaka, I. (2001) Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromus. Dis., 11, 547-555.
31. Fardeau, M., Hillaire, D., Mignard, C., Feingold, N., Feingold, J., Mignard, D., de Ubeda, B., Collin, H., Tome, F.M., Richard, I. et al. (1996) Juvenile limb-girdle muscular dystrophy. Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain, 119, 295-308.
32. Chakkalakal, J.V., Michel, S.A., Chin, E.R., Michel, R.N. and Jasmin, B.J. (2006) Targeted inhibition of Ca2+/calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Hum. Mol. Genet., 15, 1423-1435.
33. Handschin, C. and Spiegelman, B.M. (2006) Peroxisome proliferatoractivated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev., 27, 728-735.
34. Handschin, C., Rhee, J., Lin, J., Tarr, P.T. and Spiegelman, B.M. (2003) An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle. Proc. Natl Acad. Sci. USA, 100, 7111-7116.
35. Handschin, C., Kobayashi, Y.M., Chin, S., Seale, P., Campbell, K.P. and Spiegelman, B.M. (2007) PGC-1alpha regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev., 21, 770-783.
36. Hahn, C.G. and Covault, J. (1990) Isolation of transcriptionally active nuclei from striated muscle using Percoll density gradients. Anal. Biochem., 190, 193-197.
37. Kirkland, P.A., Busby, J., Stevens, S. Jr. and Maupin-Furlow, J.A. (2006) Trizol-based method for sample preparation and isoelectric focusing of halophilic proteins. Anal. Biochem., 351, 254-259.
38. Kramerova, I., Kudryashova, E., Tidball, J.G. and Spencer, M.J. (2004) Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet., 13, 1373-1388.
39. Saenz, A., Azpitarte, M., Armananzas, R., Leturcq, F., Alzualde, A., Inza, I., Garcia-Bragado, F., De la Herran, G., Corcuera, J., Cabello, A. et al. (2008) Gene expression profiling in limb-girdle muscular dystrophy 2A. PLoS One, 3, e3750.
40. Bakay, M., Zhao, P., Chen, J. and Hoffman, E.P. (2002) A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul. Disord., 12 (Suppl. 1), S125-S141.
41. Haslett, J.N., Sanoudou, D., Kho, A.T., Han, M., Bennett, R.R., Kohane, I.S., Beggs, A.H. and Kunkel, L.M. (2003) Gene expression profiling of Duchenne muscular dystrophy skeletal muscle. Neurogenetics, 4, 163-171.
42. Gardner-Medwin, D. and Walton, J.N. (1974) The clinical examination of voluntary muscles. In Walton, J.N. (ed.), Disorders of Voluntary Muscles. Churchill Livingstone, Edinburgh, UK, pp. 517-560.